1 Bodding P O. Santal Medicine. 2nd ed. Calcutta: Janasiksha Prochar Kendra, 1983. 226-302
[2]
2 Nadkarni K M. Indian Materia Medica. 3rd ed. Bombay: Popular Book Depot, 1954. 78-106？？
[3]
3 Jain S K, Tarafder C R. Medicinal plantlore of the santals (a review of P. O. bodding’s work). Econ Bot, 1970, 24: 241-278？？
[4]
4 Joe B, Vijaykumar M, Lokesh B R. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr,2004, 44: 97-111？？
[5]
5 Hafner-Bratkovic I, Gaspersic J, Smid L M, et al. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein—a new mechanism for the inhibition of PrPSc accumulation. J Neurochem, 2008, 104: 1553-1564？？
[6]
6 Ono K, Hasegawa K, Naiki H, et al. Curcumin has potent anti-amyloidogenic effects for Alzheimer''s beta-amyloid fibrils in vitro. J Neurosci Res, 2004, 75: 742-750？？
[7]
7 Reinke A A, Gestwicki J E. Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des, 2007, 70: 206-215？？
[8]
8 De Clercq E. Current lead natural products for the chemotherapy of human immunodefiency virus (HIV) infection. Med Res ReV, 2000, 20:323-349？？
[9]
9 Goel A, Kunnumakkara A B, Aggarwal B B. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol, 2008, 75: 787-809？？
[10]
10 Strimpakos A S, Sharma R A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal, 2008, 10: 511-545？？
[11]
11 Jagetia G C, Aggarwal B B. “Spicing up” of the immune system by curcumin. J Clin Immunol, 2007, 27: 19-35？？
[12]
12 Aggarwal B B, Kumar A, Aggarwal M S, et al. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. Phytopharmaceuticals in Cancer Chemopre-Vention. In: Bagchi D, Preuss H G, eds. Boca Raton, FL: CRC Press, 2005. 349-387？？
[13]
13 Shishodia S, Sethi G, Aggarwal B B. Curcumin: getting back to the roots. Ann N Y Acad Sci, 2005, 1056: 206-217？？
[14]
14 Bilmen J G, Khan S Z, Javed M U H, et al. Inhibition of the SERCA Ca2+ pumps by curcumin-Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem, 2001, 268: 6318-6327？？
[15]
15 Ingolfsson H I, Koeppe R E, Andersen O S. Curcumin is a modulator of bilayer material properties. Biochemistry, 2007, 46: 10384-10391？？
[16]
16 Hung W C, Chen F Y, Lee C C, et al. Membrane-thinning effect of curcumin. Biophys J, 2008, 94: 4331-4338？？
[17]
17 Sun Y, Lee C C, Hung W C, et al. The bound states of amphipathic drugs in lipid bilayers: study of curcumin. Biophys J, 2008, 95:2318-2324？？
[18]
18 Barry J, Fritz M, Brender J R, et al. Determining the efects of lpophilic dugs on mmbrane sructure by slid-sate NMR sectroscopy: the case of the antioxidant crcumin. J Am Chem Soc, 2009, 131: 4490？？
[19]
19 Tien H T, Salamon Z. Fomation of self-assembled lipid bilayers on solid substrates. Bioelectrochem Bioenerg, 1989, 22: 211？？
[20]
20 Sugawara M, Kojima K, Sazawa H, et al. Ion-channel sensors. Anal Chem, 1987, 59: 2842？？
[21]
21 Harris J J, Bruening M L. Electrochemical and in situ ellipsometric investigation of the permeability and stability of layered polyelectrolyte films. Langmuir, 2000, 16: 2006？？
[22]
22 Stanic Z, Voulgaropoulos A, Girousi S. Electroanalytical study of the antioxidant and antitumor agent curcumin. Electroanal, 2008, 20:1263-1266？？
[23]
23 Ding L, Li J H, Dong S J, et al. Supported phospholipid membranes: comparison among different deposition methods for a phospholipid monolayer. J Electroanal Chem, 1996, 416: 105-112？？
[24]
24 White S H. Temperature-depended structural-changes in planar bilayer membranes-solvent freeze-out. Biochim Biophys Acta, 1974, 356:8-16？？
